PlainRecalls
FDA Drug Moderate Class II Terminated

Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Mandideep 462 046 INDIA, NDC 68180-405-01

Reported: April 29, 2020 Initiated: April 15, 2020 #D-1252-2020

Product Description

Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Mandideep 462 046 INDIA, NDC 68180-405-01

Reason for Recall

Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.

Details

Units Affected
4,518 bottles
Distribution
Nationwide with the United States and Puerto Rico.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Mandideep 462 046 INDIA, NDC 68180-405-01. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 4,518 bottles.
Why was this product recalled?
Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 29, 2020. Severity: Moderate. Recall number: D-1252-2020.